Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Shrinkage of the cerebellum (cerebellar atrophy), Brisk reflexes, Overactive reflexes (hyperreflexia), and Scarring in the brain (gliosis) and others; and common findings: Gaze-evoked nystagmus, Cerebral cortical atrophy, Gait ataxia, and Gait imbalance and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 14 | Cerebral cortical atrophy, Gait ataxia, Gait imbalance |
GDAP2 encodes ganglioside induced differentiation associated protein 2 (497 aa). Highest expression in Testis (5.4 TPM) and Cervix Endocervix (4.7 TPM).
Spinocerebellar ataxia, autosomal recessive 27 is strongly associated with mutations in the GDAP2 gene on chromosome 1.
GDAP2 is classified as a druggable target with score 0.0.
Genetic testing for GDAP2 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for spinocerebellar ataxia, autosomal recessive 27 has been reported in the published literature.
Phenotype severity distribution: 5 always present features, 17 common features.
No clinical trials have been registered for spinocerebellar ataxia, autosomal recessive 27.
9 publications have been identified in PubMed for spinocerebellar ataxia, autosomal recessive 27. Research spans Diagnostic / Biomarker (22%), Review / Meta-Analysis (22%), and Case Report / Case Series (22%).
Zheng KM (2026). [PMID: 41851873](https://pubmed.ncbi.nlm.nih.gov/41851873/). *BMC Neurol*. [Case Report / Case Series]
Novis LE (2025). [PMID: 39920364](https://pubmed.ncbi.nlm.nih.gov/39920364/). *Cerebellum*. [Review / Meta-Analysis]
Ruggieri AG (2025). [PMID: 41373471](https://pubmed.ncbi.nlm.nih.gov/41373471/). *Int J Mol Sci*. [Case Report / Case Series]
Milne SC (2025). [PMID: 39520242](https://pubmed.ncbi.nlm.nih.gov/39520242/). *Ann Neurol*. [Clinical Trial Publication]
Di Folco C (2025). [PMID: 40832806](https://pubmed.ncbi.nlm.nih.gov/40832806/). *Mov Disord*. [Diagnostic / Biomarker]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 8:14 PM UTC
Online Mendelian Inheritance in Man
Eyes | 3 | Gaze-evoked nystagmus, Jerky ocular pursuit movements, Hypermetric saccades |
Muscles | 3 | Shrinkage of the cerebellum (cerebellar atrophy), Cerebral cortical atrophy, Frequent falls |
Arms and legs | 1 | Lower limb hypertonia |
Digestive system | 1 | Difficulty swallowing (dysphagia) |
Earnshaw R (2024). [PMID: 39117117](https://pubmed.ncbi.nlm.nih.gov/39117117/). *Neurobiol Dis*. [Basic Science / Preclinical]
Rudaks LI (2024). [PMID: 38760634](https://pubmed.ncbi.nlm.nih.gov/38760634/). *Cerebellum*. [Review / Meta-Analysis]
Scaravilli A (2024). [PMID: 38847051](https://pubmed.ncbi.nlm.nih.gov/38847051/). *Mov Disord*. [Diagnostic / Biomarker]